Delivery Order SPE2DB20D3103-SPE2DB24FL8U5

Award Date 12/12/23
Potential Completion Date 12/13/23
Potential Value $4.4K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order worth $3,291.24 for the pharmaceutical product WEGOVY 1.7 MG/0.75 ML PEN 0.75ML. The award was made by the Defense Logistics Agency (DLA), a defense agency, with a completion date of May 7, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds significant Indefinite Delivery Contracts (IDCs) with the DLA and the Department of Justice Federal Bureau of Investigation,...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $8,037.58 for the supply of the pharmaceutical product WEGOVY 2.4 MG/0.75 ML PEN 0.75ML. The award was made by the Defense Logistics Agency (DLA), a major procurement agency for the Department of Defense (DoD), and has an ultimate completion date of August 15, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $5,028.23 for the pharmaceutical product WEGOVY 2.4 MG/0.75 ML PEN 0.75ML. The award was made by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00,...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the pharmaceutical product WEGOVY 1.7 MG/0.75 ML PEN 0.75ML. The $3,291.24 firm-fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) on September 12, 2023, with a completion date of September 13, 2023. The contract does not have a set-aside designation. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) is a delivery order valued at $7,925.59 for the supply of the pharmaceutical product WEGOVY 0.25 MG/0.5 ML PEN 0.5ML. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation, indicating open competition. Amerisourcebergen is a major pharmaceutical distributor that holds significant Indefinite Delivery Contracts (IDCs) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $9,307.25, is a delivery order for the pharmaceutical product WEGOVY 2.4 MG/0.75 ML PEN 0.75ML. This award is not associated with a set-aside program and was made through full and open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant Indefinite Delivery...
This federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical was made to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,061.92 delivery order contract is for the pharmaceutical product WEGOVY 1.7 MG/0.75 ML PEN 0.75ML and has a completion date of February 23, 2024. The contract is a firm fixed price delivery order and was not set aside for any particular business type. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,421.32, is a delivery order for the drug WEGOVY 1 MG/0.5 ML PEN 0.5ML. The contract has an ultimate completion date of April 4, 2025 and is a firm fixed price contract. Amerisourcebergen Drug Corp is the prime contractor, and the contract is not designated as a set-aside. This award is part of...
This federal contract award was made by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $24,650.85 firm fixed-price delivery order is for the medication WEGOVY 0.5 MG/0.5 ML PEN 0.5ML, a specialty pharmaceutical product. The contract has an ultimate completion date of May 1, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which has a significant...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of the pharmaceutical product WEGOVY 2.4 MG/0.75 ML PEN 0.75ML. The $3,081.48 firm fixed price contract was awarded by the Defense Logistics Agency (DLA), a defense agency, with an ultimate completion date of April 16, 2024. The contract is a delivery order and was awarded without a set-aside designation. Amerisourcebergen is a major supplier of pharmaceuticals and...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB24FL8U5
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $4,388.32 for the supply of the medication WEGOVY 2.4 MG/0.75 ML PEN 0.75ML. The contract, awarded by the Defense Logistics Agency (DLA), has a completion date of December 13, 2023 and is a firm fixed-price contract.

Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with the DLA and the Department of Justice Federal Bureau of Investigation, valued up to $999,999,999.00 and $750,000.00 respectively. These IDCs enable the company to efficiently provide a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, and other critical care materials, to support military, veterans, and other federal healthcare programs.

The contract award does not indicate any set-aside designation, suggesting it was awarded through full and open competition. Amerisourcebergen Drug Corp's role as a prime contractor and its extensive experience in government healthcare supply chains make it a key vendor for the DLA and other federal agencies in meeting their pharmaceutical and medical supply needs.

Generated 2/27/25, 11:10 AM